Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation
- PMID: 2456512
Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation
Abstract
Although infection with cytomegalovirus (CMV) continue to be recognized relatively frequently after organ transplantation, a decrease in their severity has been described with the use of newer immunosuppressive regimens. In particular whereas antithymocyte globulin was associated with an increase in morbidity and mortality, the use of cyclosporin A has resulted in a decrease in the frequency of symptomatic infections. Several sources of CMV infection in transplant recipients are: immunosuppression secondary to drug therapy can result in reactivation of the latent infection present before transplantation; blood transfusion, either pretransplant red blood cell transfusion or blood required at the time of surgery can also result in transmission of CMV and primary infection; the transplanted kidney or heart, particularly in situations in which seropositive organs are transmitted into seronegatives can serve as the vehicle for transmission. Recent data suggest that transmission of organ donor CMV can occur even in seropositive recipients. The clinical manifestations of CMV infection in transplant recipients range from asymptomatic or mild mononucleosis syndromes to severe infection. It is generally accepted that primary infections in patients who were seronegative before transplantation are more severe than reactivated infections. Involvement of multiple organ systems has been common, with retinitis, pneumonitis and gastrointestinal manifestations occurring most commonly. A specific CMV infection of the kidney has also been described but its manifestations are variable. The association of CMV infections with rejection remains controversial in human transplantation.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients.Arch Intern Med. 1989 Sep;149(9):2095-100. Arch Intern Med. 1989. PMID: 2549896
-
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.Transpl Infect Dis. 2000 Sep;2(3):112-7. Transpl Infect Dis. 2000. PMID: 11429021 Clinical Trial.
-
DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report.J Heart Transplant. 1987 Jul-Aug;6(4):199-203. J Heart Transplant. 1987. PMID: 2822880
-
[The significance of cytomegalovirus infection in the period after a heart transplant].Rev Esp Cardiol. 1995;48 Suppl 7:108-14. Rev Esp Cardiol. 1995. PMID: 8775825 Review. Spanish.
-
Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.Semin Respir Infect. 2002 Dec;17(4):265-73. doi: 10.1053/srin.2002.36447. Semin Respir Infect. 2002. PMID: 12497543 Review.
Cited by
-
Evaluation of a leukocyte stabilization reagent for use in the cytomegalovirus pp65 antigenemia assay.J Clin Microbiol. 1998 Nov;36(11):3410-1. doi: 10.1128/JCM.36.11.3410-3411.1998. J Clin Microbiol. 1998. PMID: 9774608 Free PMC article.
-
Cytomegalovirus infection and disease after liver transplantation. An overview.Dig Dis Sci. 1992 May;37(5):673-88. doi: 10.1007/BF01296422. Dig Dis Sci. 1992. PMID: 1314159 Review.
-
Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts.Am J Pathol. 1995 Aug;147(2):461-75. Am J Pathol. 1995. PMID: 7639338 Free PMC article.
-
Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification.J Clin Microbiol. 1992 Sep;30(9):2359-65. doi: 10.1128/jcm.30.9.2359-2365.1992. J Clin Microbiol. 1992. PMID: 1328287 Free PMC article.
-
Prospective cytomegalovirus surveillance in paediatric renal transplant patients.Pediatr Nephrol. 1993 Feb;7(1):55-60. doi: 10.1007/BF00861569. Pediatr Nephrol. 1993. PMID: 8382506